Tim Dobbyn
page
1
of
1
prev |
AT&T mulling whether, how to revise T-Mobile deal
Dec 12, 2011 14:24 EST
(Reuters) - AT&T is considering whether or not it will try to revise its planned purchase of T-Mobile USA, the company's first signal that it may have to give up on the proposed $39 billion merger.
Pfizer lifts dividend, OKs $10 billion in new buybacks
Dec 12, 2011 13:32 EST
(Reuters) - Pfizer Inc <PFE.N>, the world's biggest drugmaker, on Monday authorized up to $10 billion worth of additional stock repurchases and raised its quarterly dividend by 10 percent.
Regulators could sanction Falcone over trading
Dec 09, 2011 16:12 EST
(Reuters) - Philip Falcone, a hedge fund manager who became an overnight billionaire by betting on the collapse on the U.S. housing market, is now fighting to keep his career afloat.
MF Global clients to get $2.2 billion
Dec 09, 2011 15:50 EST
NEW YORK, Dec 9 (Reuters) - A judge approved a $2.2 billion transfer to U.S. commodities customers of fallen brokerage MF Global on Friday as a trustee acknowledged there were suspicious transfers leading up to its October 31 collapse.
HP opens webOS mobile software to others
Dec 09, 2011 14:34 EST
(Reuters) - Hewlett Packard has decided to open its webOS mobile operating system to developers and companies, potentially taking on Google's free Android platform that is popular with handset makers.
MF Global clients to get $2.2 billion
Dec 09, 2011 14:22 EST
NEW YORK (Reuters) - A judge approved a $2.2 billion transfer to U.S. commodities customers of fallen brokerage MF Global on Friday as a trustee acknowledged there were suspicious transfers leading up to its October 31 collapse.
FDA panel backs Pfizer's drug for kidney cancer
Dec 07, 2011 14:47 EST
SILVER SPRING, Maryland (Reuters) - Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer.
FDA panel backs Pfizer's drug for kidney cancer
Dec 07, 2011 12:50 EST
SILVER SPRING, Md., Dec 7 - Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer.
Congress turns up heat on CFTC, MF Global's Corzine
Dec 06, 2011 18:15 EST
WASHINGTON (Reuters) - Lawmakers examining the collapse of MF Global skewered the top U.S. futures regulator for sitting out his agency's probe of the bankrupt brokerage, whose former chief executive, Jon Corzine, is due to face his own drubbing later this week.
Congress turns up heat on CFTC, MF Global's Corzine
Dec 06, 2011 17:25 EST
WASHINGTON (Reuters) - Lawmakers examining the collapse of MF Global skewered the top U.S. futures regulator for sitting out his agency's probe of the bankrupt brokerage, whose former chief executive, Jon Corzine, is due to face his own drubbing later this week.
Congress turns up heat on CFTC, MF Global's Corzine
Dec 06, 2011 17:25 EST
WASHINGTON (Reuters) - Lawmakers examining the collapse of MF Global skewered the top U.S. futures regulator for sitting out his agency's probe of the bankrupt brokerage, whose former chief executive, Jon Corzine, is due to face his own drubbing later this week.
Court approves Lehman plan to exit bankruptcy
Dec 06, 2011 16:36 EST
NEW YORK (Reuters) - Lehman Brothers Holdings Corp, now just the odds and ends of the global financial behemoth that collapsed in September 2008, received court approval on Tuesday to exit bankruptcy early next year.
FDA takes aim at "unproven" HCG weight-loss brands
Dec 06, 2011 11:50 EST
NEW YORK - (Reuters) - U.S. regulators have taken first steps to remove from the market over-the-counter products containing HCG hormone, saying the homeopathic formulations fraudulently claim to produce weight loss and may pose serious health risks.
Insight: Stem cell therapy poised to come in from the cold
Dec 05, 2011 08:09 EST
(Reuters) - A rogue surgeon injects stem cells from a fetus into a sick man's brain. The cells morph and form body parts. When the man dies, the pathologist finds cartilage, skin and bone clumped in his brain.
Insight: Stem cell therapy poised to come in from the cold
Dec 04, 2011 11:06 EST
(Reuters) - A rogue surgeon injects stem cells from a fetus into a sick man's brain. The cells morph and form body parts. When the man dies, the pathologist finds cartilage, skin and bone clumped in his brain.
Senators seek details of Pfizer Lipitor deals
Dec 01, 2011 21:42 EST
WASHINGTON (Reuters) - Three leading senators are inquiring into drugmaker Pfizer Inc's efforts to limit the sale of generic versions of its Lipitor cholesterol drug, which lost U.S. patent protection this week.
Senators introduce bill to ease path to IPOs
Dec 01, 2011 19:44 EST
WASHINGTON (Reuters) - Two senators introduced legislation on Thursday that would reduce the costs of going public for small and medium-sized companies by exempting them from certain regulatory requirements.
Cybersecurity bill approved by House panel
Dec 01, 2011 19:03 EST
(Reuters) - A bill to let U.S. spy agencies share intelligence on cyber threats with private companies was backed by a House of Representatives intelligence panel on Thursday.
Cybersecurity bill approved by House panel
Dec 01, 2011 19:02 EST
(Reuters) - A bill to let U.S. spy agencies share intelligence on cyber threats with private companies was backed by a House of Representatives intelligence panel on Thursday.
Senators seek details of Pfizer Lipitor deals
Dec 01, 2011 17:19 EST
WASHINGTON (Reuters) - Three leading U.S. senators are inquiring into drugmaker Pfizer Inc's efforts to limit the sale of generic versions of its Lipitor cholesterol drug, which lost U.S. patent protection on Wednesday.
